HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, will report fourth quarter and year-end 2014 financial results after the close of U.S. financial markets on Wednesday, March 11, 2015. Bellicum management will host a webcast and conference call at 5:00 p.m. Eastern that day to discuss the financial results and provide a business update.
Help employers find you! Check out all the jobs and post your resume.
